What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 4 minute read Pharma Industry News CERo Therapeutics gets FDA boost for CER-1236, eyes breakthrough in AML cell therapy CERo Therapeutics secures FDA orphan drug status for CER-1236 in AML, advancing its novel CER-T immunotherapy platform. Read what this means for investors. byPallavi MadhirajuJune 17, 2025